Translational Markers for Precision Medicine in Modifying Parkinson's Disease KU Leuven
This doctoral project, in collaboration with Janssen Pharmaceutica and Verstreken Lab at VIB-KU Leuven, contributes to the improvement of the prevention, diagnosis, and treatment of Parkinson's Disease. Today, there is an urgent need to shift the classical focus on symptomatic relief towards the modification of the initiation and progression of α-synucleinopathy leading to Parkinson's Disease. In this project, preformed α-Synuclein fibrils ...